Pillstats
Rx only · Injection, Solution · Intra-Articular

Iohexol

Brands: Omnipaque · Iohexol

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)860856
US makers3 labelers
Packages22
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

86K173K259K346K2025 Q12025 Q22025 Q32025 Q42026 Q1
244K
Rx · 2026 Q1
17.8M
Units dispensed
-19%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
GE Healthcare Inc.unknown18SUPPLYING
Medical Purchasing Solutions, LLCunknown2SUPPLYING
Amneal Pharmaceuticals Private Limitedunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 24, 2026
    RECALLRecall (Class II): GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlboroug…

    Presence of particulate matter — Recalling firm: GE Healthcare Ireland Limited — U.S. Nationwide.

  • Mar 24, 2026
    RECALLRecall (Class II): GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlboroug…

    Presence of particulate matter — Recalling firm: GE Healthcare Ireland Limited — U.S. Nationwide.

  • Oct 29, 2018
    RECALLRecall (Class II): Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 mL Vials per carton, Rx only, Dis…

    Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles. — Recalling firm: GE Healthcare Inc. Life Sciences — TN